What Happened?
, -based Nektar Promoted Jillian Thomsen as CFO
About the Company
Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and chronic pain. We leverage Nektar`s proprietary and proven chemistry platform in the discovery and design of our new drug candidates.
About the Person
Jillian Thomsen is CFO at Nektar. Previously, Jillian held various senior HR leadership roles in the industry.
Info Source
News
Short Profile